Paul E. Marik (IMA, 2026-07-24: Seventy-six-page 2026 IMA treatment guide carrying the current published ivermectin dose ladder for cancer. Aggressive therapy is 0.4-0.8 mg/kg/day (commonly 0.6) titrated to 1 mg/kg/day, taken with food, with dose reduction directed if neurological symptoms occur.
Ivermectin: 0.4-0.8 mg/kg/day (commonly 0.6 mg/kg/day), with titration up to 1 mg/kg/day if response is poor and the drug is well tolerated; take with food; reduce dose if headaches, dizziness, or other neurological symptoms occur
4
Paul E. Marik (IMA, 2026-07-24: Seventy-six-page 2026 IMA treatment guide carrying the current published ivermectin dose ladder for cancer. Aggressive therapy is 0.4-0.8 mg/kg/day (commonly 0.6) titrated to 1 mg/kg/day, taken with food, with dose reduction directed if neurological symptoms occur. C3 published protocol, current version. Study type: clinical guidance document; no patients, comparator, funder or declared conflicts printed. Doses verbatim: limited therapy 'Ivermectin: 0.2-0.4 mg/kg/day (commonly 0.3 mg/kg/day)' (p.3); aggressive therapy as quoted (p.4), oral, with food; the same guide instructs 'reduce dose if headaches, dizziness, or other neurological symptoms occur' – i.e. the publisher itself anticipates neurological dose-limiting effects. Also states on p.1 that 'while many respond to standard ivermectin dosing, a subset requires higher doses to achieve clinical benefit' and that there is 'no ideal regimen'. File is 76 pages, 97 KB of text; quote on p.4 (PDF page 4). Gap recorded: no long-term safety dataset accompanies the 0.6-1 mg/kg/day continuous schedule; the guide offers no monitoring schedule beyond symptom-based dose reduction. Also filed as IVA-36 (claims C3, C8). Study type: other.
